Mission statement · Company scope
“Our mission is to deliver significant clinical benefit to patients suffering from disorders that are linked to dysfunctional signaling of the TGF-ß family of proteins.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Problem–solution
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 25 words · reading grade 17.3
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_318b5f616fa95db6
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-04 · sec_sentence · 10-K · accession 0001664710-26-000018
View filing ↗0 to compareCompare